William Fearon, MD
Interventional Cardiology · Stanford, CANPI 1770671455
Payments from drug & device makers
What this record shows
The money is spread across several categories — travel and lodging (34.7%), consulting fees and ownership interests — rather than concentrated in one kind of arrangement. Cathworks, Inc. accounts for 64.3% of it on its own, with 14 other manufacturers making up the rest. Reporting peaked in 2019 at $30,047 and has fallen 90.3% since, to $2,922 in 2025.
Across 78 payments — averaging $876.57 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Cathworks, Inc.$44K
- Philips North America LLC$12K
- Spectrawave, Inc$3K
- Medtronic$2K
- Edwards Lifesciences$2K
- Gentuity, LLC$2K
- plus $3K from 9 others
Across 104 payments — averaging $35,011 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Medtronic$1.9M
- Abbott$1.1M
- Cathworks, Inc.$409K
- Boston Scientific$100K
- Gentuity, LLC$75K
- Edwards Lifesciences$32K
- plus $18K from 1 others
What the payments were for
- Consulting fees$21,33331%
- Speaking & faculty fees$2,4004%
- Travel & lodging$23,69735%
- Food & beverage$5,3378%
- Ownership interest$15,60623%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Cathworks, Inc. | 17 | $43,992 |
| Philips North America LLC | 6 | $11,664 |
| Spectrawave, Inc | 3 | $3,268 |
| Medtronic(2 entities) | 23 | $2,447 |
| Edwards Lifesciences | 4 | $2,423 |
| Gentuity, LLC | 1 | $1,663 |
| ZOLL Circulation Inc | 1 | $900 |
| Abbott | 10 | $622 |
| Siemens Medical Solutions USA, Inc. | 1 | $570 |
| Boston Scientific | 6 | $447 |
| Acist Medical Systems, Inc. | 2 | $141 |
| Merck | 1 | $100 |
| Neovasc Medical Inc | 1 | $75 |
| Abiomed | 1 | $35 |
| Heartflow, Inc. | 1 | $26 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- FFRangio$25,830
- FFRangio System$18,097
- IGT Systems Und$11,601
- HyperVue Imaging System$3,268
- Gentuity HF-OCT Imaging System$1,663
- Vis-Rx$1,663
- TherOx DS2 Console$900
- Catheter$900
- Downstream Cartridge$900
- COREVALVE EVOLUT R$753
- CoreValve Evolut$739
- AI-Rad Companion (Musculoskeletal)$570
- SAPIEN 3 Ultra RESILIA$222
- Ultreon$204
- Resolute$184
- ONYX FRONTIER$181
- Visia AF$177
How this compares
$68,372 in reported general payments places this provider in the 85th percentile of 585 interventional cardiology providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 56 | $75,929 |
| Repatha SureclickEvolocumab | 15 | $22,341 |
| BrilintaTicagrelor | 13 | $14,671 |
| Ranolazine ErRanolazine | 12 | $2,574 |
| Rosuvastatin Calcium | 158 | $2,393 |
| Atorvastatin Calcium | 142 | $2,149 |
| Ezetimibe | 64 | $1,990 |
| Prasugrel Hcl | 16 | $1,459 |
| ClopidogrelClopidogrel Bisulfate | 95 | $1,359 |
| Metoprolol Succinate | 51 | $921 |
| Amlodipine Besylate | 77 | $796 |
| Isosorbide Mononitrate ErIsosorbide Mononitrate | 44 | $669 |
| Carvedilol | 62 | $668 |
| Nitroglycerin | 25 | $478 |
| Losartan Potassium | 48 | $404 |
Paid to pharmacies, not to this prescriber.
Other interventional cardiology in Stanford
- Rahul SharmaStanford$1M
- Jennifer TremmelStanford$233K
- David LeeStanford$231K
- Todd BrintonStanford$150K
- Matthew Pricela Jolla$2.3M
- Frederick St GoarMountain View$2.2M
- Saibal KarThousand Oaks$1.1M
- Puneet KhannaRancho Mirage$1M
- Dennis SheehanRedwood City$900K
- Suhail DohadBeverly Hills$802K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.